News, Short Squeeze, Breakout and More Instantly...
Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results PR Newswire PRINCETON, N.J. , May 10, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing ...
Soligenix to Present at Upcoming Conferences PR Newswire PRINCETON, N.J. , May 6, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to tre...
Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa PR Newswire Includes thermostabilized Ebola vaccines MarVax™ and SuVax™ Includes nanoemulsion adjuvant compatible with lyophilization ...